BioArctic

BioArctic Shareholder Yield

Shareholder Yield of BioArctic (BIOA B.ST) as of Nov 10, 2026.

Shareholder Yield

0.00

Last updated:

Shareholder Yield of BioArctic is 2025 0.00 . Shareholder Yield of BioArctic was 2024 0.02 % . It decreases by % lower compared to the previous year.

The BioArctic Shareholder Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shareholder Yield
Date
Shareholder Yield
Jan 1, 2018
0.48 SEK
Jan 1, 2019
0.48 SEK
Jan 1, 2020
0.00 SEK
Jan 1, 2021
0.00 SEK
Jan 1, 2022
0.02 SEK
Jan 1, 2023
0.05 SEK
Jan 1, 2024
0.02 SEK
Jan 1, 2025
0.00 SEK
The BioArctic Shareholder Yield history
YEARShareholder YieldYoY
0.00-100.00%
0.02 %-59.85%
0.05 %+150.33%
0.02 %—
0.00—
0.00-100.00%
0.48 %0.00%
0.48 %-80.92%
2.53 %+558.71%
0.38 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioArctic Stock analysis

What does BioArctic do? BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioArctic stock

On Eulerpool you can find the complete historical development of Shareholder Yield BioArctic since 2006 – with annual values, charts, and detailed analysis.

Shareholder yield combines dividend yield and buyback yield to show the total cash return to shareholders. It captures both dividends and share repurchases.

To evaluate Shareholder Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Shareholder Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Shareholder Yield's BioArctic with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BioArctic

All Key Metrics — BioArctic